Scalper1 News
An executive with Bristol-Myers Squibb (BMY) said Tuesday that the company is planning a phase-three trial of its drugs nivolumab and Yervoy to treat lung cancer. The company’s stock rose nearly 6% on the news on the stock market today. At the Cowen & Co. Health Care Conference, Bristol Senior Vice President Brian Daniels responded to a question about the lung-cancer program by saying that “from the overall wealth of data, we believe we’re gaining Scalper1 News
Scalper1 News